Comparison of a glycoprotein E-based ELISA with a varicella-zoster whole-virus ELISA for the quantification of varicella vaccine immune responses in young children

Antibody response against varicella-zoster virus (VZV) is frequently assessed by whole-virus- (anti-VZV) or glycoprotein-based ELISAs. This study compared antibody concentrations measured by an assay quantifying anti-VZV glycoprotein E (anti-gE) and anti-VZV ELISA in 12–23-month-olds, receiving two...

Full description

Saved in:

Bibliographic Details
Published in:	Vaccine Vol. 38; no. 17; pp. 3300 - 3304
Main Authors:	Feyssaguet, Muriel, Berthold, Valérie, Helle, Laurent, Povey, Michael, Ravault, Stéphanie, Carryn, Stéphane, Gillard, Paul, Di Paolo, Emmanuel
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Ltd 09-04-2020 Elsevier Limited
Subjects:	Agreements Antibodies Antibodies, Viral - blood Antibody assay Antibody Formation Antibody response Antigens Chicken pox Chickenpox - prevention & control Chickenpox Vaccine - immunology Child Child, Preschool Children Clinical trials Confidence intervals ELISA Enzyme-Linked Immunosorbent Assay Glycoprotein E Glycoproteins Humans Immune response Laboratories Proteins Serology Vaccines Varicella Varicella vaccination Varicella-zoster virus Viral Envelope Proteins - immunology Viruses CI IgG GMR Glycoprotein E VZV mIU Varicella-zoster virus Children GMC gE Antibody assay ELISA Varicella vaccination
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!